National Cancer Institute; amended Notice of Meeting, 19006 [07-1849]
Download as PDF
<![CDATA[
19006
Federal Register / Vol. 72, No. 72 / Monday, April 16, 2007 / Notices
Licensing Status: Available for nonexclusive licensing.
Licensing Contact: Fatima Sayyid,
M.H.P.M.; 301/435–4521;
sayyidf@mail.nih.gov.
Dated: April 9, 2007.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E7–7108 Filed 4–13–07; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
cprice-sewell on PROD1PC66 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, SPORE in
GI and Head & Neck Cancers.
Date: June 11–12, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Shamala K. Srinivas, PhD,
Scientific Review Administrator, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
8123, Bethesda, MD 20892, 301–594–1224,
ss537t@nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
G—Education.
Date: June 26–27, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 204 Boardwalk Place,
Gaithersburg, MD 20878.
Contact Person: Sonya Roberson, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8109,
VerDate Aug<31>2005
15:24 Apr 13, 2007
Jkt 211001
Bethesda, MD 20892, 301–594–1182,
robersos@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, R25
Special Emphasis Panel (SEP).
Date: June 26, 2007.
Time: 5 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 204 Boardwalk Place,
Gaithersburg, MD 20878.
Contact Person: Robert Bird, PhD,
Scientific Review Administrator, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
8113, Bethesda, MD 20892–8328, 301–496–
7978, birdr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancer
Prevention Research Small Grant Program
(R03).
Date: June 28–29, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance M Street Hotel, 1143
New Hampshire Avenue, NW., Washington,
DC 20037.
Contact Person: Irina V. Gordienko, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
7073, MS 2829, Bethesda, MD 20892, 301–
594–1566, gordienkoiv@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
H—Clinical Groups.
Date: July 9–10, 2007.
Time: 1 p.m. to 11 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Mirage I & II,
Washington, DC 20007.
Contact Person: Timothy C. Meeker, MD,
PhD, Scientific Review Administrator,
Resources and Training Review Branch,
Division of Extramural Activities, National
Cancer Institute, 6116 Executive Boulevard,
Room 8103, Bethesda, MD 20892, (301) 594–
1279, meekert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: April 5, 2007.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1848 Filed 4–13–07; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, March
5, 2007, 12 p.m. to March 5, 2007, 4
p.m. National Institutes of Health, 6130
Executive Boulevard, Rockville, MD
20852 which was published in the
Federal Register on January 11, 2007, 72
FR1335.
The meeting notice is changed to
reflect the date change from March 5,
2007 to April 13, 2007. The meeting is
closed to the public.
Dated: April 5, 2007.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1849 Filed 4–13–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following meeting
of the Sickle Cell Disease Advisory
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Sickle Cell Disease
Advisory Committee.
Date: June 4, 2007.
Time: 8:30 a.m. to 4 p.m.
Agenda: Discussion of Programs and
Issues.
Place: National Institutes of Health,
Rockledge 6700, 6700A Rockledge Drive,
Room 354, Bethesda, MD 20817.
Contact Person: Robert B. Moore, PhD,
Health Scientist Administrator, Blood
Diseases Program, Division of Blood Disease
and Resources, National Heart, Lung, and
Blood Institute, NIH, 6701 Rockledge Drive,
Room 10162, Bethesda, MD 20892, 301/4350050.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
E:\FR\FM\16APN1.SGM
16APN1
]]>Agencies
[Federal Register Volume 72, Number 72 (Monday, April 16, 2007)]
[Notices]
[Page 19006]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1849]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Special Emphasis Panel, March 5, 2007, 12 p.m. to
March 5, 2007, 4 p.m. National Institutes of Health, 6130 Executive
Boulevard, Rockville, MD 20852 which was published in the Federal
Register on January 11, 2007, 72 FR1335.
The meeting notice is changed to reflect the date change from March
5, 2007 to April 13, 2007. The meeting is closed to the public.
Dated: April 5, 2007.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-1849 Filed 4-13-07; 8:45 am]
BILLING CODE 4140-01-M
